Status | Study |
Active, not recruiting |
Study Name: Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) Condition: Myelodysplastic Syndrome Leukemia, Myelomonocytic, Chronic Date: 2014-03-07 Interventions: Other: Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion As desc |
Active, not recruiting |
Study Name: Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) Condition: Anemia Myelodysplastic Syndromes Chr Date: 2012-11-27 Interventions: Drug: Sotatercept Sotatercept |
Completed |
Study Name: A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients Condition: Myelodysplastic Syndromes (MDS) Chronic Myelomonocytic Leukemia Date: 2012-05-24 Interventions: Drug: Panobinostat Other Name: LBH589 |
Completed |
Study Name: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2011-05-09 Interventions: Drug: Revlimid Dose escalation 5mg - 10mg - 15mg - 20mg in |
Completed |
Study Name: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2011-04-29 Interventions: Drug: 5-Azacitidine Administered on Days 1-7 of each Cycle |
Active, not recruiting |
Study Name: Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2010-12-01 Interventions: Drug: Decitabine Decitabine will be administered at a dose of 20 mg/m2 infused over a 1 hour period once |
Completed |
Study Name: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Condition: Leukemia Date: 2010-11-04 Interventions: Drug: azacitidine Other: laboratory biomar |
Completed |
Study Name: Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML) Condition: Chronic Myelomonocytic Leukemia Date: 2010-04-01 Interventions: Drug: Decitabine 20mg/m2/day, one hour intravenous infusion, every day during 5 days |
Completed |
Study Name: Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) Condition: Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Date: 2010-01-12 Interventions: Drug: Azacitidine 100 mg / m(2 |
Recruiting |
Study Name: The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia Condition: Chronic Myelomonocytic Leukemia Date: 2009-11-06 |